The following treatments do not have a goal of reducing or eliminating infection, however they have had a side effect of leading to reductions in infection rates and exacerbations in the case of CFTR modifiers or eliminating lung infection for a period of time in the case of lung transplants. The gene discussed is CFTR; the disease is infection.